Trial reportEuropean journal of nuclear medicine and molecular imaging2018
Risk-related
Trial report in European journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature.Annals of nuclear medicine · 2023Pooled it
- Same-day dual-tracer PET/CT imaging with [Annals of nuclear medicine · 2025Trial
- Integrated CT Radiomics and Circulating Tumor Cell Analysis in Predicting Lung Adenocarcinoma Invasion: A Dual-Center Study with Implications for Personalized Treatment.OncoTargets and therapy · 2026Article
- FAP-targeted PET/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic management.European journal of nuclear medicine and molecular imaging · 2025Article
- Predicting solitary pulmonary lesions in breast cancer patients usingBMC pulmonary medicine · 2024Article
- Predicting malignant potential of solitary pulmonary nodules in patients with COVID-19 infection: a comprehensive analysis of CT imaging and tumor markers.BMC infectious diseases · 2024Article
- Article
- Algorithm for Reducing Overall Biological Detriment Caused by PET/CT: an Age-Based Study.Nuclear medicine and molecular imaging · 2023Article
- Superiority of FAPI-PET/CT for examining multiple malignant tumors: a retrospective study.American journal of cancer research · 2023Article
- The Added Value ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- MRI Image Segmentation Model with Support Vector Machine Algorithm in Diagnosis of Solitary Pulmonary Nodule.Contrast media & molecular imaging · 2021Article
- Comparison of [European journal of nuclear medicine and molecular imaging · 2020Article
- FDG PET/CT in the Staging of Lung Cancer.Current radiopharmaceuticals · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDiagnosis of solitary pulmonary nodule (SPN) is an important public health issue and
methods
resultsIn the study population, 36% had malignant, 35% benign, and 29% indeterminate SPN.
conclusionPre-test probability of malignancy can guide the diagnostic strategy of
Indexed as
Identifiers
29730697What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.